SCHEMBL30109340

SCHEMBL30109340

COC(=O)c1ccc(N2CCc3ccccc3C2)cc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LIPE Q05469 1/20 0.58
▸ NPC1 O15118 4/20 0.55
▸ RAB9A P51151 3/20 0.55
▸ ALDH1A1 P00352 2/20 0.54
▸ NAMPT P43490 1/20 0.53
▸ KMT2A Q03164 3/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ EED O75530 1/20 0.51
▸ LMNA P02545 1/20 0.49
▸ THRB P10828 1/20 0.49
▸ TSHR P16473 3/20 0.46
▸ HTT P42858 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6374745 0.96 LIPE (0.55) LIPENPC1RAB9AALDH1A1NAMPT
SCHEMBL30109397 0.87 LIPE (0.51) LIPENPC1ALDH1A1NAMPTKMT2A
SCHEMBL17869278 0.85 NPC1 (0.58) LIPENPC1RAB9AALDH1A1KMT2A
SCHEMBL30109408 0.85 ALDH1A1 (0.54) LIPENPC1RAB9AALDH1A1EED
SCHEMBL28459399 0.84 RAB9A (0.79) NPC1RAB9AALDH1A1NAMPTKMT2A
SCHEMBL14158144 0.83 ESR1 (0.54) LIPENPC1RAB9AALDH1A1
SCHEMBL30109424 0.82 MEN1 (0.57) NPC1RAB9AALDH1A1KMT2AMEN1
SCHEMBL16061897 0.82 MEN1 (0.57) NPC1RAB9AALDH1A1KMT2AMEN1
SCHEMBL19284497 0.81 ALDH1A1 (0.49) LIPENPC1RAB9AALDH1A1KMT2A
SCHEMBL30109434 0.81 TSHR (0.50) NPC1RAB9AALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115557889-A 2-aryl-3, 4-dihydroisoquinoline derivative and application thereof in preparing antitumor drugs 西南交通大学 2023-01-03 — — CN claimed
CN-115557889-A 2-aryl-3, 4-dihydroisoquinoline derivative and application thereof in preparing antitumor drugs 西南交通大学 2023-01-03 — — CN disclosed
Send feedback